Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Janssen Research & Development, LLC
National Cancer Institute (NCI)
Thomas Jefferson University
M.D. Anderson Cancer Center
Medical College of Wisconsin
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Weill Medical College of Cornell University
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Ciusss de L'Est de l'Île de Montréal
MitoImmune Therapeutics
National Cancer Institute (NCI)
SCRI Development Innovations, LLC
University Hospital, Clermont-Ferrand
University of Liege
National Institutes of Health Clinical Center (CC)
Northside Hospital, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Novartis
Fred Hutchinson Cancer Center
University of Arizona
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Barbara Ann Karmanos Cancer Institute
National Institutes of Health Clinical Center (CC)
Stanford University
AbbVie
Masonic Cancer Center, University of Minnesota